MedTrace Logo

Percutaneous Needle Fasciotomy +/- Corticosteroid Injection for Dupuytren's Contracture

NCT05440240 · Status: RECRUITING · Phase: PHASE4 · Type: INTERVENTIONAL · Enrollment: 400

Last updated 2023-05-17

No results posted yet for this study

Summary

Comparing percutaneous needle fasciotomy +/- corticosteroid injection for Dupuytren's contracture affecting metacarpophalangeal joints. A clinician-initiated, multicenter, randomized controlled trial.

Conditions

  • Dupuytren Contracture
  • Dupuytren's Disease
  • Contracture
  • Joint Diseases
  • Musculoskeletal Diseases
  • Fibroma
  • Neoplasm, Fibrous Tissue
  • Neoplasms, Connective Tissue
  • Neoplasms, Connective and Soft Tissue
  • Neoplasms by Histologic Type
  • Neoplasms
  • Connective Tissue Diseases

Interventions

PROCEDURE

Percutaneous needle fasciotomy

Percutaneous needle fasciotomy ad modum Lermusiaux and Debeyre

DRUG

Corticosteroid injection

Depo-Medrol

OTHER

Saline injection

Isotonic saline

Sponsors & Collaborators

  • Regionshospitalet Silkeborg

    lead OTHER

Principal Investigators

  • Jeppe Lange, MD, PhD · Regionshospitalet Horsens

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
DOUBLE
Model
PARALLEL

Eligibility

Min Age
45 Years
Max Age
99 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2023-01-10
Primary Completion
2025-12-31
Completion
2030-03-31

Countries

  • Denmark

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05440240 on ClinicalTrials.gov